Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials.

MLA

Carvalho, Pedro E. P., et al. “Cardiovascular and Renal Effects of SGLT2 Inhibitor Initiation in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials.” Clinical Research in Cardiology : Official Journal of the German Cardiac Society, vol. 112, no. 8, Aug. 2023, pp. 1044–55. EBSCOhost, https://doi.org/10.1007/s00392-022-02148-2.

APA

Carvalho, P. E. P., Veiga, T. M. A., Simões E Silva, A. C., Gewehr, D. M., Dagostin, C. S., Fernandes, A., Nasi, G., & Cardoso, R. (2023). Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials. Clinical Research in Cardiology : Official Journal of the German Cardiac Society, 112(8), 1044–1055. https://doi.org/10.1007/s00392-022-02148-2

Chicago

Carvalho, Pedro E P, Thiago M A Veiga, Ana C Simões E Silva, Douglas M Gewehr, Caroline S Dagostin, Amanda Fernandes, Guilherme Nasi, and Rhanderson Cardoso. 2023. “Cardiovascular and Renal Effects of SGLT2 Inhibitor Initiation in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials.” Clinical Research in Cardiology : Official Journal of the German Cardiac Society 112 (8): 1044–55. doi:10.1007/s00392-022-02148-2.